Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$35.29 USD
-1.61 (-4.36%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $35.23 -0.06 (-0.17%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.32 | 0.00% |
Earnings Summary
For their last quarter, Janux Therapeutics (JANX) reported earnings of -$0.11 per share, beating the Zacks Consensus Estimate of $-0.32 per share. This reflects a positive earnings surprise of 65.63%. Look out for JANX's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year increase of 23.81%.
Earnings History
Price & Consensus
Zacks News for JANX
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services